Table 2.

Amisulpride vs Conventional Antipsychotics—Results Based on 4 Different Test Conditions

	g	CI-low	CI-up	P	F	n1	n2
Model 1: LOCF
Pooled results	0.27	0.15	0.39	0.00	21.15	825	445
Puech et al8	0.22	−0.06	0.51	0.12	2.41	194	64
Möller et al7	0.23	−0.05	0.52	0.11	2.66	95	96
Colonna et al5	0.32	0.11	0.53	0.00	9.24	368	118
Carrière et al6	0.35	0.07	0.63	0.01	6.24	97	105
Wetzel et al9	0.29	−0.05	0.64	0.09	2.88	71	62
Model 2: Completers only
Pooled results	0.20	0.05	0.34	0.01	6.86	560	261
Puech et al8	0.07	−0.27	0.41	0.68	0.17	150	43
Möller et al7	0.26	−0.09	0.60	0.15	2.16	71	59
Colonna et al5	0.35	0.07	0.63	0.02	5.95	215	62
Carrière et al6	0.28	−0.07	0.62	0.12	2.53	72	59
Wetzel et al9	−0.03	−0.45	0.38	0.87	0.03	52	38
Model 3: LOCF after exclusion of dropouts due to adverse events
Pooled results	0.23	0.11	0.35	0.00	13.57	775	380
Puech et al8	0.10	−0.21	0.40	0.53	0.40	186	54
Möller et al7	0.20	−0.10	0.49	0.19	1.77	92	86
Colonna et al5	0.37	0.15	0.58	0.00	11.63	441	106
Carrière et al6	0.26	−0.04	0.55	0.09	2.88	93	83
Wetzel et al9	0.13	−0.24	0.49	0.49	0.48	66	51
Model 4: LOCF after exclusion of all dropouts except inefficacy or recovery
Pooled results	0.25	0.11	0.39	0.00	13.09	624	307
Puech et al8	−0.02	−0.34	0.30	0.90	0.02	170	47
Möller et al7	0.20	−0.12	0.52	0.22	1.52	81	68
Colonna et al5	0.49	0.23	0.75	0.00	13.92	237	77
Carrière et al6	0.31	−0.02	0.63	0.06	3.52	78	69
Wetzel et al9	0.19	−0.19	0.58	0.32	0.99	58	46

Note: g, the effect size Hedges g; F, F value; df = n₁ + n₂ − 3; n₁, number of patients in the amisulpride group; n₂, number of patients in the conventional antipsychotic group; CI-low, lower limit of 95% confidence interval; CI-up, upper limit of 95% confidence interval; P, P value; LOCF, last-observation-carried-forward.